Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

385

Figures (1-5)

Sum=425

Publishing Process of This Article

Item

Count

Browse

Download

Sum=149

Aug 27, 2025 (publication date) through Aug 29, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Hepatol. Aug 27, 2025; 17(8): 108533
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108533

Full Size Figure Download Figure

Figure 5 Subgroup analyses based on the treatment lines in placebo disease control rate.

Citation: Chen WY, Chen Q, Wang CC, Zhang CY, Chen SK, Meng ZQ, Han P, Dong S, Chen QW. Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis. World J Hepatol 2025; 17(8): 108533
URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108533.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108533